FEMASYS INC — Director's Dealing 2021

Jun 18, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FEMASYS INC (FEMY)
CIK: 0001339005
Period of Report: 2021-06-17

Reporting Person: Dyett John (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Convertible Preferred Stock	$		Common Stock (948342)		Indirect
Series C Convertible Preferred Stock	$		Common Stock (2271453)		Indirect
Series C Convertible Preferred Stock	$		Common Stock (63709)		Indirect
Warrants (Right to Buy)	$7.25		Common Stock (55177)		Indirect
Warrants (Right to Buy)	$9.45		Common Stock (128934)		Indirect
Warrants (Right to Buy)	$9.45		Common Stock (12705)		Indirect

Footnotes

F1: Shares of Series B Convertible Preferred Stock are convertible at any time at the holder's election, without payment of additional consideration. Such shares have no expiration date but are expected to convert into Common Stock automatically upon the closing of the Issuer's initial public offering.

F2: Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein.

F3: Shares of Series C Convertible Preferred Stock are convertible at any time at the holder's election, without payment of additional consideration. Such shares have no expiration date but are expected to convert into Common Stock automatically upon the closing of the Issuer's initial public offering.

F4: Each warrant is exercisable by the holder in whole or part at any time and from time to time on or before April 16, 2025.

F5: Each warrant is exercisable by the holder in whole or part at any time and from time to time on or before December 14, 2026.

F6: Each warrant is exercisable by the holder in whole or part at any time and from time to time on or before January 6, 2027.